The neuro space is heating up, according to med-tech analyst Rick Wise of Leerink Swann, who issued a note Monday regarding Johnson & Johnson's (J&J; New Brunswick, New Jersey) plan to acquire Micrus Endovascular (San Jose, California) in a cash for stock exchange valued at about $480 million. (Medical Device Daily) Read More
